Aside from differences in cell source (primary leukemia blasts versus cell lines) the continuous exposure of cells to DNA damaging drugs may account for the difference between our data and published literature, where the introduction of FLT3-ITD into cell lines has been associated with resistance to DNA damage induced apoptosis [36], [38]. The gene discussed is FLT3; the disease is leukemia.